IGF DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT
Key facts
| Status | Awarded |
|---|---|
| Estimated value | $66,032,644.47 |
| Submission deadline | Deadline not published |
| Published | Jul 28, 2017 |
| Buyer | National Institutes of Health |
| Country | United States · MD |
| CPV code | NAICS 541711 (RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY) · PSC AN12 |
| Source | USAspending.gov Federal Contract Awards ↗ |
- Status
- Awarded
- Estimated value
- $66,032,644.47
- Submission deadline
- Deadline not published
- Published
- Jul 28, 2017
- Country
- United States
- CPV code
- NAICS 541711 (RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY) · PSC AN12
- Source
- USAspending.gov Federal Contract Awards
Contract outcome & evergreen alternatives
This notice is no longer open for submissions. The original remains available for reference.
| Awarded supplier / winner | Registration / LEI number | Country | Awarded contract amount | Award date |
|---|---|---|---|---|
| THE EMMES COMPANY, LLC | US-UEI: NBQCBJ6FXBU4 | United States | $66,032,644.47 | Jul 28, 2017 |
Checked:
The original notice takes precedence. Its status and conditions can change after collection.
Description
IGF DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT
Awarding Agency: Department of Health and Human Services — National Institutes of Health.
NAICS 541711: RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY.
PSC AN12: HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH.
Period of Performance: 2017-07-28 to 2027-05-28.